Injective has launched perpetual futures markets for private equity, providing unprecedented access to high-growth companies like OpenAI, SpaceX, and Anthropic. This development democratizes investment in pre-IPO firms, previously limited to institutional and accredited investors. By shifting these futures to the blockchain, Injective aims to meet demand from retail traders seeking exposure before public offerings. Perpetual futures, unlike traditional derivatives, have no expiration, allowing traders to maintain positions indefinitely. The platform will initially offer contracts linked to notable startups, expanding its offerings with companies valued in the tens of billions, including xAI and Revolut. Injective’s collaboration with Republic is enhancing the flow of retail capital into private equity, marking a significant milestone in tokenized assets. However, risks such as volatile valuations and regulatory challenges remain. As Injective processes substantial trading volumes, the coming months will be crucial for understanding investor interest and market viability.
Source link
Share
Read more